Efficacy and safety of anlotinib versus docetaxel in advanced non-small cell lung cancer after first-line treatment failure
LIU Liya
ZHU Ying
TU Changling
JIANG Bo
Machine-generated Keywords：
Publication Date：2021-04-20
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 177-181 )